. Author manuscript; available in PMC: 2016 Aug 3.

Published in final edited form as: Cancer. 2015 Mar 4;121(12):1985–1992. doi: 10.1002/cncr.29277

TABLE 2.

Second Primary Malignancies Detected on Surveillance Imaging

cHL Stage at Presentation	Radiation Field	Interval From CMT to Diagnosis (mo)	Second Primary Malignancy		Treatment	Outcome
cHL Stage at Presentation	Radiation Field	Interval From CMT to Diagnosis (mo)	Type	Stage	Treatment	Outcome
IIXB	Mini-mantle	24	Clear cell renal cell carcinoma	I	Partial nephrectomy	Disease-free
IIA	Mini-mantle	4	Thyroid cancer	III	Surgery and radioactive iodine	Disease-free
IA	IFRT: right axilla	52	T-cell lymphoma: abdomen	IIBS	Chemotherapy	Death
IAX	IFRT: neck/upper mediastinum	96	Gastroesophageal junction adenocarcinoma	IIIA	Chemotherapy	Recurrence therapy

Abbreviations: CMT, combined-modality therapy; IFRT, involved-field radiotherapy.